Key numbers

 

BIOShelter

 

A revolutionary new material

BCI has begun the development of a prototype proprietary biomaterial, BIOShelter, which involves the treatment of bovine pericardial patches with the FACTA technology.

Currently, the manufacturing industry uses glutaraldehyde as a fixative agent, which, while being indispensable and irreplaceable for sterilizing the tissue and strengthening it from a mechanical point of view, is known to have toxic effects in humans. Could FACTA® be designed as a nontoxic substitute for glutaraldehyde?

 

BIOShelter

A revolutionary new material

BCI has begun the development of a prototype proprietary biomaterial, BIOShelter, which involves the treatment of bovine pericardial patches with the FACTA technology.

Currently, the manufacturing industry uses glutaraldehyde as a fixative agent, which, while being indispensable and irreplaceable for sterilizing the tissue and strengthening it from a mechanical point of view, is known to have toxic effects in humans. Could FACTA® be designed as a nontoxic substitute for glutaraldehyde?

BIOShelter applications

 

A new type of ductile biomaterial

BIOShelter is a new material in the form of a patch, or "sheet", of animal-origin connective tissue. This patch is obtained from the bovine pericardium, an organ consisting of a connective matrix made up almost exclusively of collagen, which is very ductile and suitable for the construction of bioprostheses in general, from heart valves to reparation uses in the vascular and aesthetic surgery.